121 related articles for article (PubMed ID: 9851518)
1. Macrophage- and lymphocyte-produced Th1 and Th2 cytokines in the tumour microenvironment.
Fridman WH; Tartour E
Res Immunol; 1998; 149(7-8):651-3. PubMed ID: 9851518
[No Abstract] [Full Text] [Related]
2. An assessment of the immunological status of patients with renal cell carcinoma based on the relative abundance of T-helper 1- and -2 cytokine-producing CD4+ cells in peripheral blood.
Onishi T; Ohishi Y; Goto H; Tomita M; Abe K
BJU Int; 2001 Jun; 87(9):755-9. PubMed ID: 11412209
[TBL] [Abstract][Full Text] [Related]
3. Functional tumor infiltrating TH1 and TH2 effectors in large early-stage cervical cancer are suppressed by regulatory T cells.
Adurthi S; Mukherjee G; Krishnamurthy H; Sudhir K; Bafna UD; Umadevi K; Jayshree RS
Int J Gynecol Cancer; 2012 Sep; 22(7):1130-7. PubMed ID: 22872166
[TBL] [Abstract][Full Text] [Related]
4. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
5. Inflammation driven by tumour-specific Th1 cells protects against B-cell cancer.
Haabeth OA; Lorvik KB; Hammarström C; Donaldson IM; Haraldsen G; Bogen B; Corthay A
Nat Commun; 2011; 2():240. PubMed ID: 21407206
[TBL] [Abstract][Full Text] [Related]
6. Th1 cytokines are more effective than Th2 cytokines at licensing anti-tumour functions in CD40-activated human macrophages in vitro.
Luheshi N; Davies G; Poon E; Wiggins K; McCourt M; Legg J
Eur J Immunol; 2014 Jan; 44(1):162-72. PubMed ID: 24114634
[TBL] [Abstract][Full Text] [Related]
7. Dietary fatty acids influence the production of Th1- but not Th2-type cytokines.
Wallace FA; Miles EA; Evans C; Stock TE; Yaqoob P; Calder PC
J Leukoc Biol; 2001 Mar; 69(3):449-57. PubMed ID: 11261793
[TBL] [Abstract][Full Text] [Related]
8. [Expression of cytokines Th1 and Th2 in patients with esophageal squamous cell carcinoma].
Chen PC; Feng JG; Ling YT
Zhonghua Zhong Liu Za Zhi; 2007 Nov; 29(11):850-1. PubMed ID: 18396645
[No Abstract] [Full Text] [Related]
9. CD4(+) T cell frequencies and Th1/Th2 cytokine patterns expressed in the acute and memory response to respiratory syncytial virus I-E(d)-restricted peptides.
Tripp RA; Hou S; Etchart N; Prinz A; Moore D; Winter J; Anderson LJ
Cell Immunol; 2001 Jan; 207(1):59-71. PubMed ID: 11161454
[TBL] [Abstract][Full Text] [Related]
10. Immunosuppression affects CD4+ mRNA expression and induces Th2 dominance in the microenvironment of cutaneous squamous cell carcinoma in organ transplant recipients.
Kosmidis M; Dziunycz P; Suárez-Fariñas M; Mühleisen B; Schärer L; Läuchli S; Hafner J; French LE; Schmidt-Weber C; Carucci JA; Hofbauer GF
J Immunother; 2010 Jun; 33(5):538-46. PubMed ID: 20463594
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-2 in the treatment of renal cell carcinoma and malignant melanoma.
Eklund JW; Kuzel TM
Cancer Treat Res; 2005; 126():263-87. PubMed ID: 16209070
[No Abstract] [Full Text] [Related]
12. Topical imiquimod and intralesional interleukin-2 increase activated lymphocytes and restore the Th1/Th2 balance in patients with metastatic melanoma.
Green DS; Dalgleish AG; Belonwu N; Fischer MD; Bodman-Smith MD
Br J Dermatol; 2008 Sep; 159(3):606-14. PubMed ID: 18616776
[TBL] [Abstract][Full Text] [Related]
13. Cytokine profiles of in vivo activated thyroid-infiltrating T cells cloned in the presence or absence of interleukin 4.
Guo J; Rapoport B; McLachlan SM
Autoimmunity; 1997; 26(2):103-10. PubMed ID: 9546811
[TBL] [Abstract][Full Text] [Related]
14. Cancer immunotherapy comes of age.
Rosenberg SA
Nat Clin Pract Oncol; 2005 Mar; 2(3):115. PubMed ID: 16264884
[No Abstract] [Full Text] [Related]
15. Cytokines and simian immunodeficiency virus infections.
Rosenberg YJ; Lewis MG; Villinger F; Ansari AA
Res Immunol; 1994; 145(8-9):706-12; discussion 712-3. PubMed ID: 7754224
[No Abstract] [Full Text] [Related]
16. Proteoglycan (aggrecan)-induced arthritis in BALB/c mice is a Th1-type disease regulated by Th2 cytokines.
Finnegan A; Mikecz K; Tao P; Glant TT
J Immunol; 1999 Nov; 163(10):5383-90. PubMed ID: 10553063
[TBL] [Abstract][Full Text] [Related]
17. Shift in Th1 (IL-2 and IFN-gamma) and Th2 (IL-10 and IL-4) cytokine mRNA balance within two new histological main-types of rheumatoid-arthritis (RA).
Ruschpler P; Stiehl P
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):285-93. PubMed ID: 12030433
[TBL] [Abstract][Full Text] [Related]
18. Photoactivational cytokine-modulatory action of 8-methoxypsoralen plus ultraviolet A in lymphocytes, monocytes, and cutaneous T cell lymphoma cells.
Tokura Y; Seo N; Yagi H; Takigawa M
Ann N Y Acad Sci; 2001 Sep; 941():185-93. PubMed ID: 11594572
[TBL] [Abstract][Full Text] [Related]
19. Characteristic cytokine products of Th1 and Th2 cells in hemodialysis patients.
Daichou Y; Kurashige S; Hashimoto S; Suzuki S
Nephron; 1999; 83(3):237-45. PubMed ID: 10529630
[TBL] [Abstract][Full Text] [Related]
20. Modeling anti-tumor Th1 and Th2 immunity in the rejection of melanoma.
Eftimie R; Bramson JL; Earn DJ
J Theor Biol; 2010 Aug; 265(3):467-80. PubMed ID: 20450922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
